Primary information |
---|
sequence ID | Seq_1311 |
Peptide sequence | DGVSGGEGKGGSDGGGSHRKEGEEADAPG |
CancerPDF_ID | CancerPDF_ID3500, |
PMID | 27026199 |
Protein Name | "CD99 antigen, CD99" |
UniprotKB Entry Name | CD99_HUMAN |
Fluid | Urine |
fdr | 2655.15 |
Profiling Technique | "CE-MS, Micro-TOF-MS" |
Peptide Identification technique | MS-MS |
Labelled/Label Free | Label Free |
CancerPDF_ID | CancerPDF_ID3500, |
p-Value | less than 0.05 |
Software | Proteome Discoverer 1.2 |
Length | 29 |
Cancer Type | Bladder cancer |
Database | Uniprot Human non-redundant Database |
Modification | NA |
Number of Patients | 451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls); |
Regulation | Differentially expressed between primary UBC and normal individual |
Validation | Independent Validation |
Sensitivity | For testing dataset 91% |
Specificity | For testing dataset 68% |
Accuracy | For testing dataset 76% |
Peptide Atlas | NA |
IEDB | NA |